Abstract
Background Thrombolysis is considered to be standard therapy for patients with pulmonary embolism presenting with shock, despite a paucity of large clinical trials. The benefit of thrombolysis in submassive pulmonary embolism (right ventricular dysfunction without shock) is debated.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
